Differential in vivo and in vitro effect of gentamicin on glutamate synthesis and glutamate deamination in rabbit kidney-cortex tubules and mitochondria.
The effect of gentamicin on both glutamate synthesis and glutamate deamination was studied in kidney-cortex mitochondria and tubules isolated from both control and gentamicin-treated animals. In kidney-cortex mitochondria which were permeabilized in order to make a free access of substrates and antibiotic to the glutamate dehydrogenase, gentamicin appeared to be a very potent inhibitor of glutamate synthesis, resulting in about 60% decrease of the enzyme activity at 5 mM concentration. Other aminoglycoside antibiotics decreased the enzymatic activity, in the following order: gentamicin > neomycin = tobramycin = kanamycin > biodacyna > amikacin > streptomycin. This, in principle, corresponds to their known nephrotoxic potential observed in vivo. The inhibitory action of antibiotics was abolished by neither ADP nor leucine, allosteric activators of glutamate dehydrogenase. Surprisingly, gentamicin did not decrease the rate of ammonia formation from glutamate when added to both renal tubules and mitochondria isolated from control rabbits. This indicates that the antibiotic exerts its inhibitory effect on glutamate dehydrogenase activity in the direction of glutamate synthesis only. In contrast, the rate of both glutamate deamination and glutamate synthesis was about 40% lower in renal tubules and mitochondria isolated from kidney-cortex of animals which were given antibiotics for 10 days. In view of these results it seems that (i) the depression of ammoniagenesis in gentamicin-treated animals may be due to a decrease of glutamate dehydrogenase content and (ii) under conditions in vitro the aminoglycoside inhibits the enzyme activity in the direction of glutamate synthesis while it does not affect the glutamate deamination.
Bryła
J
J
Institute of Biochemistry, Warsaw University, Poland.
Lietz
T
T
Jarzyna
R
R
Michalik
M
M
Pietkiewicz
J
J
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000641:Ammonia / Q000378:metabolism; D000818:Animals; D003641:Deamination; D005839:Gentamicins / Q000494:pharmacology*; D005969:Glutamate Dehydrogenase / Q000378:metabolism; D005971:Glutamates / Q000096:biosynthesis / Q000378:metabolism*; D018698:Glutamic Acid; D007672:Kidney Cortex / Q000187:drug effects / Q000378:metabolism*; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism*; D011817:Rabbits; D014031:Tobramycin / Q000494:pharmacology
D005839:Gentamicins; D005971:Glutamates; D018698:Glutamic Acid; D000244:Adenosine Diphosphate; D000641:Ammonia; D005969:Glutamate Dehydrogenase; D014031:Tobramycin